TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF GLOBAL DEEP BRAIN STIMULATION SYSTEMS MARKET 20
1.4 LIMITATIONS 21
1.5 MARKETS COVERED 22
2 MARKET SEGMENTATION 24
2.1 MARKETS COVERED 24
2.2 GEOGRAPHICAL SCOPE 25
2.3 YEARS CONSIDERED FOR THE STUDY 26
2.4 CURRENCY AND PRICING 26
2.5 DBMR TRIPOD DATA VALIDATION MODEL 27
2.6 MULTIVARIATE MODELLING 30
2.7 PRODUCTS LIFELINE CURVE 30
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.9 DBMR MARKET POSITION GRID 32
2.10 VENDOR SHARE ANALYSIS 33
2.11 MARKET APPLICATION COVERAGE GRID 34
2.12 SECONDARY SOURCES 35
2.13 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 40
5 EPIDEMIOLOGY 42
6 MARKET OVERVIEW 43
6.1 DRIVERS 45
6.1.1 RISING CASES OF NEUROLOGICAL DISORDERS 45
6.1.2 GROWING ACCEPTANCE OF MINIMALLY INVASIVE PROCEDURES 47
6.1.3 RISE IN NUMBER OF PRODUCTS SEEKING APPROVAL 48
6.1.4 IMPROVES QUALITY OF LIFE AND REDUCES THE DISEASE SYMPTOMS 50
6.2 RESTRAINTS 51
6.2.1 HIGH COST OF DEEP BRAIN STIMULATION DEVICES AND SURGERY 51
6.2.2 STRICT REGULATIONS 52
6.2.3 POST-OPERATIVE LIMITATIONS OF DEEP BRAIN STIMULATION SYSTEMS 52
6.3 OPPORTUNITIES 53
6.3.1 ADVANCEMENT IN NOVEL TECHNOLOGIES 53
6.3.2 INCREASING HEALTHCARE EXPENDITURE FOR NEUROLOGICAL DISORDERS 54
6.3.3 MEDICAL TOURISM 55
6.3.4 EMERGING ECONOMY 56
6.4 CHALLENGES 57
6.4.1 HIGH RISK AND COMPLICATIONS OF DEEP BRAIN STIMULATION SURGERY 57
6.4.2 LOW ACCEPTANCE AMONG PATIENTS 58
6.4.3 MALFUNCTION OF THE STIMULATOR 59
7 GLOBAL DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE 60
1.1. OVERVIEW 61
7.1.1 SINGLE-CHANNEL DEEP BRAIN STIMULATOR 62
7.1.2 DUAL CHANNEL DEEP BRAIN STIMULATOR 63
8 GLOBAL DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION 64
8.1 OVERVIEW 65
8.1.1 PARKINSON'S DISEASE 66
8.1.2 ESSENTIAL TREMOR 67
8.1.3 DYSTONIA 67
8.1.4 EPILEPSY 68
8.1.5 OBSESSIVE-COMPULSIVE DISORDER 69
9 GLOBAL DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE 70
9.1 OVERVIEW 71
9.1.1 RECHARGEABLE 72
9.1.2 NON-RECHARGEABLE 73
10 GLOBAL DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER 74
10.1 OVERVIEW 75
10.1.1 HOSPITALS 76
10.1.2 NEUROLOGICAL CLINIC 77
10.1.3 AMBULATORY SURGICAL CENTERS (ASC'S) 77
11 GLOBAL DEEP BRAIN STIMULATION SYSTEMS MARKET, BY GEOGRAPHY 78
11.1 OVERVIEW 79
11.2 NORTH AMERICA 84
11.2.1 U.S. 89
11.2.2 CANADA 91
11.2.3 MEXICO 93
11.3 EUROPE 95
11.3.1 GERMANY 100
11.3.2 FRANCE 102
11.3.3 U.K. 104
11.3.4 ITALY 106
11.3.5 SPAIN 108
11.3.6 SWITZERLAND 110
11.3.7 RUSSIA 112
11.3.8 NETHERLAND 114
11.3.9 BELGIUM 116
11.3.10 TURKEY 118
11.3.11 REST OF EUROPE 120
11.4 ASIA-PACIFIC 121
11.4.1 CHINA 126
11.4.2 JAPAN 128
11.4.3 SOUTH KOREA 130
11.4.4 INDIA 132
11.4.5 AUSTRALIA 134
11.4.6 SINGAPORE 136
11.4.7 THAILAND 138
11.4.8 MALAYSIA 140
11.4.9 INDONESIA 142
11.4.10 PHILIPPINES 144
11.4.11 REST OF ASIA-PACIFIC 146
11.5 SOUTH AMERICA 147
11.5.1 BRAZIL 152
11.5.2 REST OF SOUTH AMERICA 154
11.6 MIDDLE EAST AND AFRICA 155
11.6.1 SOUTH AFRICA 160
11.6.2 REST OF MIDDLE EAST AND AFRICA 162
12 GLOBAL DEEP BRAIN STIMULATION SYSTEMS MARKET, COMPANY LANDSCAPE 163
12.1 COMPANY SHARE ANALYSIS: GLOBAL 163
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 164
12.3 COMPANY SHARE ANALYSIS: EUROPE 165
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 166
?
13 COMPANY PROFILE 167
13.1 MEDTRONIC 167
13.1.1 COMPANY SNAPSHOT 167
13.1.2 REVENUE ANALYSIS 167
13.1.3 COMPANY SHARE ANALYSIS 168
13.1.4 PRODUCT PORTFOLIO 168
13.1.5 RECENT DEVELOPMENT 168
13.2 BOSTON SCIENTIFIC CORPORATION 169
13.2.1 COMPANY SNAPSHOT 169
13.2.2 REVENUE ANALYSIS 169
13.2.3 COMPANY SHARE ANALYSIS 170
13.2.4 PRODUCT PORTFOLIO 170
13.2.5 RECENT DEVELOPMENTS 171
13.3 ABBOTT 172
13.3.1 COMPANY SNAPSHOT 172
13.3.2 REVENUE ANALYSIS 172
13.3.3 COMPANY SHARE ANALYSIS 173
13.3.4 PRODUCT PORTFOLIO 173
13.3.5 RECENT DEVELOPMENT 173
13.4 ALEVA NEUROTHERAPEUTICS SA 174
13.4.1 COMPANY SNAPSHOT 174
13.4.2 PRODUCT PORTFOLIO 174
13.4.3 RECENT DEVELOPMENT 174
13.5 NEUROPACE, INC. 175
13.5.1 COMPANY SNAPSHOT 175
13.5.2 PRODUCT PORTFOLIO 175
13.5.3 RECENT DEVELOPMENT 175
13.6 BEIJING PINS MEDICAL CO., LTD. 176
13.6.1 COMPANY SNAPSHOT 176
13.6.2 PRODUCT PORTFOLIO 176
13.6.3 RECENT DEVELOPMENT 176
13.7 SCENERAY CORPORATION, LIMITED 177
13.7.1 COMPANY SNAPSHOT 177
13.7.2 PRODUCT PORTFOLIO 177
13.7.3 RECENT DEVELOPMENT 177
13.8 FISHER WALLACE 178
13.8.1 COMPANY SNAPSHOT 178
13.8.2 PRODUCT PORTFOLIO 178
13.8.3 RECENT DEVELOPMENT 178
14 SWOT ANALYSIS 179
15 QUESTIONNAIRE 182
16 RELATED REPORTS 184
?